SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001145443-06-003471
Filing Date
2006-11-21
Accepted
2006-11-21 16:40:33
Documents
22
Period of Report
2006-05-31

Document Format Files

Seq Description Document Type Size
1 d20273_20f.htm 20-F 1389903
2 GRAPHIC d20273_graph1.jpg GRAPHIC 19035
3 GRAPHIC d20273_graph2.jpg GRAPHIC 13874
4 d20273_ex1-6.htm EX-99.1(6) 15206
5 GRAPHIC ca_logo.jpg GRAPHIC 3269
6 GRAPHIC canada_logo.jpg GRAPHIC 11700
7 GRAPHIC printedname.jpg GRAPHIC 12564
8 GRAPHIC richardgshaw_sig.jpg GRAPHIC 19060
9 GRAPHIC secretary.jpg GRAPHIC 10237
10 GRAPHIC sig.jpg GRAPHIC 23870
11 d20273_ex2-1.htm EX-99.2(1) 189984
12 d20273_ex2-2.htm EX-99.2(2) 199294
13 d20273_ex2-3.htm EX-99.2(3) 173882
14 d20273_ex2-5.htm EX-99.2(5) 586708
15 d20273_ex4-1.htm EX-99.4(1) 207540
16 d20273_ex4-2.htm EX-99.4(2) 5580
17 d20273_ex8-1.htm EX-99.8(1) 3211
18 d20273_ex11-1.htm EX-99.11(1) 41642
19 d20273_ex12-1.htm EX-99.12(1) 7689
20 d20273_ex12-2.htm EX-99.12(2) 7715
21 d20273_ex13-1.htm EX-99.13(1) 2778
22 d20273_ex13-2.htm EX-99.13(2) 2821
  Complete submission text file 0001145443-06-003471.txt   2993300
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-32001 | Film No.: 061233243
SIC: 2836 Biological Products, (No Diagnostic Substances)